6-145800238-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032145.5(FBXO30):āc.2106C>Gā(p.Asp702Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,612,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO30 | NM_032145.5 | c.2106C>G | p.Asp702Glu | missense_variant | 3/3 | ENST00000237281.5 | NP_115521.3 | |
FBXO30 | NM_001348092.2 | c.2106C>G | p.Asp702Glu | missense_variant | 3/3 | NP_001335021.1 | ||
FBXO30 | XM_047419398.1 | c.2214C>G | p.Asp738Glu | missense_variant | 3/3 | XP_047275354.1 | ||
EPM2A-DT | NR_038246.1 | n.53-28123G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO30 | ENST00000237281.5 | c.2106C>G | p.Asp702Glu | missense_variant | 3/3 | 1 | NM_032145.5 | ENSP00000237281.3 | ||
EPM2A-DT | ENST00000629681.1 | n.90+740G>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152076Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250332Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135240
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460816Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 726732
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152076Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74290
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2021 | The c.2106C>G (p.D702E) alteration is located in exon 3 (coding exon 2) of the FBXO30 gene. This alteration results from a C to G substitution at nucleotide position 2106, causing the aspartic acid (D) at amino acid position 702 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at